Evidence map›Paper›PMID 37511268›Full record

ArticleInternational journal of molecular sciences2023

Loss of ANCO1 Expression Regulates Chromatin Accessibility and Drives Progression of Early-Stage Triple-Negative Breast Cancer.

Meng Yuan, Megan E Barefoot, Kendell Peterson, Moray J Campbell, Jan K Blancato, Manjing Chen, Marcel O Schmidt, Amber J Kiliti, Hong-Bin Fang, Anton Wellstein and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Translational lung cancer research · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Meng YuanLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.
Megan E BarefootLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.
Kendell PetersonLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.
Moray J CampbellDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Jan K BlancatoLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.ORCID 0000-0001-7442-8411
Manjing ChenDepartment of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC 20057, USA.ORCID 0009-0002-8280-6413
Marcel O SchmidtLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.ORCID 0000-0002-3991-2766
Amber J KilitiLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.ORCID 0000-0002-8581-6222
Hong-Bin FangDepartment of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC 20057, USA.ORCID 0000-0002-6173-9082
Anton WellsteinLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.ORCID 0000-0002-0570-4950
Anna T RiegelLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.ORCID 0000-0001-6585-8612
Ghada M SharifLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.ORCID 0000-0001-5344-3575
Georgetown University · USCedars-Sinai Medical Center · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Louis M Weiner · 1990 to 2026
$71.5M
TRAINING GRANT IN TUMOR BIOLOGYT32CA009686 · NCI · GEORGETOWN UNIVERSITY · PI ANNA Tate RIEGEL, DAVID J ROBBINS · 1996 to 2026
$10.8M
(PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast CancerR01CA205632 · NCI · GEORGETOWN UNIVERSITY · PI RIEGEL, ANNA TATE · 2016 to 2020
$2.3M
Development of clinically relevant models of DCISR21CA226542 · NCI · GEORGETOWN UNIVERSITY · PI RIEGEL, ANNA TATE · 2019 to 2020
$369k
Decoding the Tissue of Origin of Cellular Damage from Cell-free DNA in Liquid BiopsiesF30CA250307 · NCI · GEORGETOWN UNIVERSITY · PI BAREFOOT, MEGAN EVELYN · 2021 to 2025
$176k
NCI NIH HHS F30 CA250307NCI NIH HHS P30 CA051008NCI NIH HHS R01 CA205632NCI NIH HHS R21 CA226542NCI NIH HHS T32 CA009686NIH HHS F30CA250307NIH HHS R01CA205632NIH HHS R21CA226542NIH HHS T32CA009686
6 · The paper itself

Abstract

Mutations in the gene ankyrin repeat domain containing 11 (

Indexed as

ChromatinTriple Negative Breast NeoplasmsAnimalsCell Line, TumorCell MovementCell ProliferationDNA-Binding ProteinsEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansMicePhosphatidylinositol 3-KinasesRepressor ProteinsANKRD11 protein, humanAnkrd11 protein, mouseChromatinDNA-Binding ProteinsPhosphatidylinositol 3-KinasesRepressor ProteinsANCO1ANKRD11breast cancer enhancerTNBCtumor suppressor

Identifiers

PMID37511268
PMCPMC10380654
OpenAlexW4384525966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.